Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Treasury Shares (2017 - 2025)

Historic Treasury Shares for Marimed (MRMD) over the last 9 years, with Q3 2025 value amounting to $8.5 million.

  • Marimed's Treasury Shares rose 2665.17% to $8.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.5 million, marking a year-over-year increase of 2665.17%. This contributed to the annual value of $7.7 million for FY2024, which is 3228.18% up from last year.
  • As of Q3 2018, Marimed's Treasury Shares stood at $643000.0, which was up 152888.89% from $545000.0 recorded in Q2 2018.
  • In the past 5 years, Marimed's Treasury Shares registered a high of $10.6 million during Q2 2025, and its lowest value of $79815.0 during Q3 2021.
  • Moreover, its 5-year median value for Treasury Shares was $5.6 million (2023), whereas its average is $5.3 million.
  • Over the last 5 years, Marimed's Treasury Shares had its largest YoY gain of 152888.89% in 2018, and its largest YoY loss of 152888.89% in 2018.
  • Marimed's Treasury Shares (Quarter) stood at $25000.0 in 2017, then skyrocketed by 2472.0% to $643000.0 in 2018.
  • Its Treasury Shares was $8.5 million in Q3 2025, compared to $10.6 million in Q2 2025 and $10.6 million in Q1 2025.